Christine Martin
Directeur/Membre du Conseil chez STORM Therapeutics Ltd.
Provenance du réseau au premier degré de Christine Martin
Entité | Type d'entité | Industrie | |
---|---|---|---|
Cambridge Enterprise Ltd.
Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge.
47
| Subsidiary | Investment Managers | 47 |
Biotica Technology Ltd.
Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB.
16
| Extinct | Pharmaceuticals: Major | 16 |
STORM Therapeutics Ltd.
STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom.
9
| Holding Company | Biotechnology | 9 |
Pharmenable Ltd.
Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Polyprox Therapeutics Ltd.
Polyprox Therapeutics Ltd. BiotechnologyHealth Technology Polyprox Therapeutics Ltd. operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases. The company was founded by Laura S. Itzhaki in 2018 and is headquartered in Cambridge, the United Kingdom.
4
| Holding Company | Biotechnology | 4 |
SDS Therapeutics Ltd.
SDS Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services SDS Therapeutics Ltd. is a British biotechnology company founded in 2020 that provides research and development services. The company is based in Cambridge, UK.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Z Factor Ltd.
Z Factor Ltd. BiotechnologyHealth Technology Z Factor Ltd. operates as a drug discovery company. It identifies and develops therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was founded by James Huntington in 2015 and is headquartered in Babraham, the united Kingdom.
3
| Subsidiary | Biotechnology | 3 |
Qkine Ltd.
Qkine Ltd. Pharmaceuticals: OtherHealth Technology Qkine Ltd. provides growth factors and bioactive proteins for use in stem cell science and regenerative medicine applications. Its products include Activin A and FGF2. The firm specializes in protein purification, organoids, cytokines, and protein-engineering. The company was founded by Marko Hyvonen and Catherine Elton in 2016 and is headquartered in Cambridge, the United Kingdom.
3
| Holding Company | Pharmaceuticals: Other | 3 |
Spirea Ltd.
Spirea Ltd. BiotechnologyHealth Technology Spirea Ltd. operates as a healthcare technology company. It develops smart polymer platform for the controlled delivery of drug combinations to maximise the clinical impact of medicines. The company was founded by Myriam Ouberai and is headquartered in arrogate, the United Kingdom.
3
| Holding Company | Biotechnology | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Christine Martin via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
The Wellcome Trust Ltd.
The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
BVF, Inc.
BVF, Inc. Investment Banks/BrokersFinance BVF, Inc. manages engages in investment business and manages biotech focused hedge funds. The firm manages Biotechnology Value Fund LP and Biotechnology Value Fund II LP. The company was founded by Mark Nathan Lampert on September 14, 1993 and is headquartered in San Francisco, CA. | Investment Banks/Brokers | Founder Corporate Officer/Principal | |
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Cellzome Ltd.
Cellzome Ltd. Pharmaceuticals: MajorHealth Technology Cellzome Ltd. engages in the research, development, and manufacture of pharmaceutical products. It provides kinase-targeted drugs to treat inflammatory diseases. The company was founded by Gitte Neubauer on December 22, 2003 and is headquartered in Middlesex, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Innovate UK
Innovate UK Miscellaneous Commercial ServicesCommercial Services Innovate UK promotes, supports and invests in technology research, development, and commercialization. The firm provides access to information about the funding and support opportunities through a range of channels. The company was founded on July 1, 2007 and is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of Oxford | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Wellcome Plc
Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Wellcome Plc is a British company that specializes in the discovery, development, manufacture, and sale of human healthcare products. The company is based in Greenford, UK. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Hexagen Plc
Hexagen Plc BiotechnologyHealth Technology Part of Incyte Corp., Hexagen Plc develops technology for the discovery of single nucleotide polymorphisms. The British company was founded by Andrew Peter Sandham, Stephen William Bunting. Hexagen was acquired by Incyte Corp. on September 22, 1998 for $25.99 million. | Biotechnology | Founder Chief Executive Officer | |
University of Cambridge | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Graduate Degree Masters Business Admin Graduate Degree Graduate Degree | |
University of Leeds | College/University | Doctorate Degree Undergraduate Degree | |
Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Masters Business Admin | |
University of London | College/University | Doctorate Degree Doctorate Degree | |
Pfizer Venture Investments LLC
Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments LLC (Pfizer Ventures Investments) is a venture capital subsidiary of Pfizer Inc. founded in 2001. The firm is headquartered in New York. | Investment Managers | Private Equity Investor Private Equity Investor | |
University of Durham | College/University | Doctorate Degree Undergraduate Degree | |
Chroma Therapeutics Ltd.
Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member Founder Founder | |
Cancer Research Technology Ltd.
Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Medical Specialties | Chief Executive Officer Director/Board Member | |
IP2IPO Innovations Ltd.
IP2IPO Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services IP2IPO Innovations Ltd. provides business development and technology transfer services. The firm also provides strategic industry University partnerships, patenting, licensing, spin-out incubation and equity management services. The company was founded in 1986 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer President Corporate Officer/Principal | |
The Cambridge Angels
The Cambridge Angels Investment ManagersFinance The Cambridge Angels (Cambridge Angels) is a venture capital firm founded in 1999 by Robert Sansom, David Cleevely and Doug Richard. The firm is headquartered in London, United Kingdom. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Octopus Ventures Ltd.
Octopus Ventures Ltd. Investment ManagersFinance Octopus Ventures Ltd. (Octopus Ventures) is a venture capital firm Founded by Alan Wallace in 1999. The firm is headquartered in London. | Investment Managers | Private Equity Investor Private Equity Investor | |
London Business School | College/University | Masters Business Admin Masters Business Admin | |
Biotechnology & Biological Sciences Research Council
Biotechnology & Biological Sciences Research Council Miscellaneous Commercial ServicesCommercial Services Biotechnology & Biological Sciences Research Council operates a funding agency for academic research and training. It funds bioscience, people and research infrastructure that helps to tackle major challenges such as the impact of climate change, a healthier old age, and sustainable food production, land use and energy production. The company is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal | |
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Chairman Director/Board Member Chairman | |
BICYCLE THERAPEUTICS PLC | Biotechnology | Chairman Director/Board Member | |
ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
ams Sensors UK Ltd.
ams Sensors UK Ltd. Industrial MachineryProducer Manufacturing AMS Sensors UK Ltd. provides gas sensor solutions for consumer applications. The company was founded on June 20, 2007 and is headquartered in Cambridge, the United Kingdom. | Industrial Machinery | Founder Director/Board Member | |
The Institute of Directors (United Kingdom)
The Institute of Directors (United Kingdom) Miscellaneous Commercial ServicesCommercial Services The Institute of Directors (United Kingdom) is a community of passionate UK business leaders. The non-profit company is based in Birmingham, UK, and has subsidiaries in the United Kingdom. The British company provides professional training opportunities and access to essential help and resources for its members. The CEO of the company is Stephen Martin. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
OXFORD BIODYNAMICS PLC | Biotechnology | Director/Board Member | |
Autifony Therapeutics Ltd.
Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
MISSION Therapeutics Ltd.
MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Martlet Capital
Martlet Capital Investment ManagersFinance Martlet Capital (Marlet Capital) is a venture capital subsidiary of Marshall of Cambridge (Holdings) Ltd founded in 2011 by Peter Lawton Cowley and Robert Marshall. The firm is headquartered in Cambridge, United Kingdom. | Investment Managers | Private Equity Investor Consultant / Advisor | |
Xenikos BV
Xenikos BV Medical SpecialtiesHealth Technology Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands. | Medical Specialties | Director/Board Member Director/Board Member | |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Cambridge Judge Business School | College/University | Masters Business Admin Corporate Officer/Principal | |
Cambridge Innovation Capital Ltd
Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | Investment Managers | Director/Board Member Consultant / Advisor Private Equity Investor | |
Levicept Ltd.
Levicept Ltd. Pharmaceuticals: GenericHealth Technology Levicept Ltd. develops a biological therapy for the treatment of osteoarthritis and chronic pain. Its treatments include p75NTR-Fc and LEVI-04. The company was founded by Simon Lempriere Westbrook on August 23, 2012 and is headquartered in Sandwich, the United Kingdom. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
Isomerase Therapeutics Ltd.
Isomerase Therapeutics Ltd. BiotechnologyHealth Technology Isomerase Therapeutics Ltd. operates as a drug discovery and development company. It specializes in biosynthetic medicinal chemistry and synthetic biology, microbial natural products, microbial natural products, and semisynthetic chemistry. The company was founded by Barrie Wilkinson, Matthew Gregory, and Steven Moss in 2012 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Chief Executive Officer Founder Founder | |
Morphogen-IX Ltd.
Morphogen-IX Ltd. Miscellaneous Commercial ServicesCommercial Services Morphogen-IX Ltd. operates as a biotechnology company. It develops bone morphogenetic proteins as a novel therapy for the treatment of Pulmonary Arterial Hypertension. The company was founded in 2015 and is headquartered in Babraham, the United Kingdom. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Investment Managers | Founder Founder Private Equity Investor | |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Elasmogen Ltd.
Elasmogen Ltd. Pharmaceuticals: MajorHealth Technology Elasmogen Ltd. develops soloMER products for treatment of auto-immune mediated and inflammatory diseases. The company is headquartered in Aberdeen, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
UltraHuman Ltd.
UltraHuman Ltd. Miscellaneous Commercial ServicesCommercial Services UltraHuman Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Sandwich, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Critical Pressure Ltd.
Critical Pressure Ltd. Pharmaceuticals: MajorHealth Technology Critical Pressure Ltd. engages in research and experimental development on biotechnology. The firm develops products to treat vascular dysfunction and shock. The company is headquartered in Babraham, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Diamond Edge Ventures, Inc.
Diamond Edge Ventures, Inc. Investment ManagersFinance Diamond Edge Ventures, Inc (Diamond Edge ventures) is a venture capital subsidiary of Mitsubishi Chemical Holdings Corp founded in 2018. The firm is headquartered in San Francisco, California. | Investment Managers | Director/Board Member | |
CENTESSA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chairman Corporate Officer/Principal |
Statistiques
Internationale
Royaume-Uni | 42 |
Etats-Unis | 8 |
Danemark | 2 |
Pays-Bas | 2 |
Sectorielle
Health Technology | 22 |
Finance | 11 |
Commercial Services | 10 |
Consumer Services | 9 |
Miscellaneous | 2 |
Opérationnelle
Director/Board Member | 305 |
Corporate Officer/Principal | 122 |
Founder | 58 |
Private Equity Investor | 50 |
Chairman | 47 |
Relations les plus connectées
Insiders | |
---|---|
Elaine Jones | 37 |
Francesco de Rubertis | 36 |
Alan J. Lewis | 33 |
David Grainger | 29 |
Bobby G. Soni | 23 |
David Holbrook | 23 |
Andrew Peter Sandham | 22 |
Ajay Chowdhury | 21 |
Peter S. Ringrose | 19 |
Hakan Goker | 18 |
Anthony Charles Hickson | 18 |
Tim Edwards | 16 |
Mark Nathan Lampert | 15 |
Michael Anstey | 14 |
Jeffrey Moore | 13 |
- Bourse
- Insiders
- Christine Martin
- Connexions Sociétés